Skip to search.
 BSE Down2.74% NSE Down2.86%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NMS

8.17 20 Jun 1:30AM

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending31-Mar-201331-Dec-201230-Sep-201230-Jun-2012
Net Income (2,789) 8,621   21,312   18,070  
Operating Activities, Cash Flows Provided By or Used In
Depreciation(6,052)377  (404)(700)
Adjustments To Net Income(7,007)11,265  (801)(6,310)
Changes In Accounts Receivables52,735  (1,170)771  (29,370)
Changes In Liabilities(17,695)(9,883)(10,165)35,205  
Changes In Inventories(2,774)(242)(3,131)824  
Changes In Other Operating Activities(827)(494)10,927  (376)
Total Cash Flow From Operating Activities 21,643   8,097   18,913   18,043  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(44)(8)(2)(210)
Investments -  1,019  (1,929)44,283  
Other Cash flows from Investing Activities -   -  (133,264)(25,435)
Total Cash Flows From Investing Activities (44) 1,011   (135,195) 18,638  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock(700)1,439  (6,562)1,841  
Net Borrowings -   -  75,000   -  
Other Cash Flows from Financing Activities(384)(942)(166)(7)
Total Cash Flows From Financing Activities (1,084) (12,767) 69,368   4,015  
Effect Of Exchange Rate Changes(140)74  43  85  
Change In Cash and Cash Equivalents 20,375   (3,585) (46,871) 40,781  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.